Acetylsalicylic Acid
Vertebral Artery Dissection
London Health Sciences CentrePhase 3Active
BB
68/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 55/ 100
- Competitive Position
- 95/ 100
Competitive context
2 Active assets in the Vertebral Artery Dissection cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Plavix St George's, University of London | Phase 3 | BB |
WARFARIN St George's, University of London | Phase 3 | BB |
Dipyridamole St George's, University of London | Phase 3 | BB |
Unfractionated Heparin St George's, University of London | Phase 3 | B |
Onabotulinum Toxin A University of Alberta | Phase 1 | NR |
Acetylsalicylic Acid London Health Sciences Centre | Early Phase 1 | NR |
Same molecule, other indications
Acetylsalicylic Acid is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →